Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia or Schizoaffective”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01888107
What this trial is testing

Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen-Cilag S.p.A. 347
Early research (Phase 1)Study completedNCT00796081
What this trial is testing

A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 25
Early research (Phase 1)Study completedNCT00791349
What this trial is testing

QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141
Large-scale testing (Phase 3)Study completedNCT00088465
What this trial is testing

Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenic DisordersSchizoaffective Disorder
Eli Lilly and Company 931
Post-approval studies (Phase 4)WithdrawnNCT00672464
What this trial is testing

Cardio Risk of Acute Schizophrenia Olanzapine Duke

Who this might be right for
SchizophreniaSchizoaffective Disorder
Duke University
Testing effectiveness (Phase 2)Study completedNCT01393600
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 37
Post-approval studies (Phase 4)Study completedNCT00845507
What this trial is testing

Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults

Who this might be right for
Weight Gain
University of Cincinnati 54
Large-scale testing (Phase 3)Study completedNCT05779241
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005

Who this might be right for
SchizophreniaSchizoaffective Disorder
Lyndra Inc. 83
Not applicableStudy completedNCT00512070
What this trial is testing

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Seattle Institute for Biomedical and Clinical Research 40
Not applicableStudy completedNCT02160249
What this trial is testing

RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)

Who this might be right for
Schizophrenia Spectrum DisorderSchizophreniaSchizoaffective Disorder+1 more
London School of Hygiene and Tropical Medicine 166
Not applicableStudy completedNCT02600741
What this trial is testing

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 296
Post-approval studies (Phase 4)Study completedNCT00208169
What this trial is testing

Abilify Therapy for Reducing Comorbid Substance Abuse

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+3 more
Creighton University 30
Not applicableStudy completedNCT05633108
What this trial is testing

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

Who this might be right for
Psychotic Disorders
Eisai Co., Ltd. 579,728
Early research (Phase 1)Ended earlyNCT01568203
What this trial is testing

First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

Who this might be right for
Schizophrenia
Amgen 50
Not applicableStudy completedNCT00179062
What this trial is testing

Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderDepressive Disorder, Major+1 more
Vanderbilt University 300
Post-approval studies (Phase 4)Study completedNCT00423878
What this trial is testing

Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
National Institute of Mental Health (NIMH) 215
Post-approval studies (Phase 4)Study completedNCT00378183
What this trial is testing

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Who this might be right for
Schizoaffective DisorderSchizophrenia
Janssen, LP 120
Large-scale testing (Phase 3)Study completedNCT00558298
What this trial is testing

A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen, LP 811
Post-approval studies (Phase 4)Ended earlyNCT02140788
What this trial is testing

Effects of Metformin and Fish Oil on Treatment With Clozapine

Who this might be right for
SchizophreniaSchizo-affective Disorder
Duke University 34
Not applicableEnded earlyNCT01368458
What this trial is testing

Conversion to Antipsychotic Monotherapy

Who this might be right for
SchizophreniaSchizoaffective Disorder
Nathan Kline Institute for Psychiatric Research 24
Next Page